News
Learn how combining 3 specific food types prevents dangerous blood sugar spikes after eating, plus timing tips for optimal ...
Harmony remains committed to vigorously defending its intellectual property and will continue litigating its consolidated patent infringement case against several other companies that have filed ANDAs ...
Hypertension, a global health crisis affecting over a billion adults, significantly elevates the risk of stroke, aneurysm, ...
The global sales of anemia treatment are estimated to be worth USD 12,287.3 million in 2025 and are anticipated to reach a value of USD 23,903.5 million by 2035. Sales are projected to rise at a CAGR ...
New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...
9h
MedPage Today on MSNTwo Drugs Better Than One for Easing Albuminuria in CKD Patients With DiabetesThe standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...
A genetic mutation that fuses two genes drives several different cancer types by forming networks of protein interactions that alter gene expression in cells, a study by UT Southwestern Medical Center ...
Patients with diabetic kidney disease (DKD) and anemia have no worse, and possibly better, cardiovascular outcomes from finerenone treatment.
Update: Prime Biome Reviews Reveal Groundbreaking Gut Microbiome, Skin Barrier, and Dysbiosis Correction Benefits Backed by New Clinical Findings WASHINGTON, PA / ACCESS Newswire / June 5, 2025 / ...
Why Healthletic Ultimate Methylene Blue Is the #1 Trusted Brain Supplement of 2025 for Focus, Energy, and Cognitive Clarity NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / In This Article, You'll ...
Adding an SGLT2 inhibitor to finerenone in CKD and type 2 diabetes yields “remarkable” albuminuria reductions that may, if ...
Brian Slomovitz, MD, of Mount Sinai Medical Center, compares relacorilant plus nab-paclitaxel with existing treatments for platinum-resistant ovarian cancer and highlights the ROSELLA trial’s global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results